Heart Fail Rev 22(1):2539
In 2025, the American Diabetes Association updated their recommendations and said that Ozempic and other GLP-1s should be considered as a first line therapy for certain high-risk patients
Recent researches suggested the internalization of receptors is the key point and thus more dynamic studies are required eagerly
Modern Weight Loss Solutions That Work With Your Body, Not Against It Our top weight loss medications are even more effective when combined
In conclusion, when considering injectable-based combination therapy, prioritizing GLP-1 RAs over basal insulin is determined as a general recommendation based on a comprehensive assessment of the balance between glucose-lowering benefits and adverse reactions, as well as the target population for application
Oxidative stress as a mediator of life history trade-offs: mechanisms, measurements and interpretation